LMAT LeMaitre Vascular, Inc. Stock Quote

LMAT [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	46.45	EPS (ttm)	0.92	Insider Own	14.60%	Shs Outstand	20.25M	Perf Week	-0.37%
Market Cap	880.27M	Forward P/E	37.98	EPS next Y	1.12	Insider Trans	-9.90%	Shs Float	17.10M	Perf Month	18.45%
Income	18.80M	PEG	-	EPS next Q	0.30	Inst Own	86.30%	Short Float	10.62%	Perf Quarter	33.43%
Sales	122.00M	P/S	7.22	EPS this Y	-20.80%	Inst Trans	0.61%	Short Ratio	14.96	Perf Half Y	53.62%
Book/sh	7.95	P/B	5.37	EPS next Y	13.77%	ROA	8.40%	Target Price	42.40	Perf Year	15.38%
Cash/sh	1.67	P/C	25.59	EPS next 5Y	-1.80%	ROE	12.30%	52W Range	18.76 - 44.52	Perf YTD	5.41%
Dividend	0.38	P/FCF	56.79	EPS past 5Y	30.80%	ROI	11.80%	52W High	-4.11%	Beta	1.38
Dividend %	0.89%	Quick Ratio	1.40	Sales past 5Y	10.50%	Gross Margin	65.70%	52W Low	127.56%	ATR	1.53
Employees	454	Current Ratio	2.30	Sales Q/Q	25.10%	Oper. Margin	19.90%	RSI (14)	65.36	Volatility	4.78% 3.48%
Optionable	Yes	Debt/Eq	0.37	EPS Q/Q	44.20%	Profit Margin	15.40%	Rel Volume	0.71	Prev Close	43.27
Shortable	Yes	LT Debt/Eq	0.22	Earnings	Oct 29 AMC	Payout	38.60%	Avg Volume	121.36K	Price	42.69
Recom	2.00	SMA20	6.61%	SMA50	11.42%	SMA200	36.93%	Volume	85,719	Change	-1.34%

Mar-16-20

Upgrade

Sidoti

Neutral → Buy

Oct-24-19

Upgrade

Lake Street

Hold → Buy

$40

Oct-24-19

Downgrade

First Analysis Sec

Strong Buy → Outperform

$37 → $40

Oct-14-19

Upgrade

First Analysis Sec

Outperform → Strong Buy

$37

Jul-25-19

Upgrade

First Analysis Sec

Neutral → Outperform

$29 → $37

Jul-25-19

Reiterated

Barrington Research

Outperform

$32 → $37

Oct-08-18

Upgrade

ROTH Capital

Neutral → Buy

Oct-08-18

Upgrade

Barrington Research

Mkt Perform → Outperform

$34

Jun-08-18

Resumed

ROTH Capital

Buy

$38

Apr-26-18

Upgrade

The Benchmark Company

Hold → Buy

$40

Apr-26-18

Downgrade

Stifel

Buy → Hold

$40 → $34

Oct-27-17

Downgrade

The Benchmark Company

Buy → Hold

Oct-27-17

Downgrade

First Analysis Sec

Overweight → Equal-Weight

$34

Jul-10-17

Downgrade

The Benchmark Company

Buy → Hold

Jul-10-17

Downgrade

Canaccord Genuity

Buy → Hold

$28

Mar-21-17

Initiated

First Analysis Sec

Overweight

$29

Feb-22-17

Downgrade

Barrington Research

Outperform → Mkt Perform

Sep-22-16

Downgrade

Sidoti

Buy → Neutral

Jul-28-16

Reiterated

Barrington Research

Outperform

$18.50 → $20

Feb-25-16

Reiterated

Barrington Research

Outperform

$14 → $15.50

Jan-13-21 07:00AM	Sidoti Virtual Investor Conference ACCESSWIRE
Jan-08-21 03:33AM	Are Strong Financial Prospects The Force That Is Driving The Momentum In LeMaitre Vascular, Inc.'s NASDAQ:LMAT) Stock? Simply Wall St.
Dec-29-20 06:03PM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Dec-09-20 11:32AM	Zacks.com featured highlights include: Winnebago, Shutterstock, Ituran Location and Control, LeMaitre Vascular and Logitech Zacks
02:19AM	Is Now An Opportune Moment To Examine LeMaitre Vascular, Inc. (NASDAQ:LMAT)? Simply Wall St.
Dec-07-20 05:18PM	Is LMAT A Good Stock To Buy Now? Insider Monkey
Nov-17-20 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) Zacks
11:52AM	Should You Be Tempted To Sell LeMaitre Vascular (LMAT) Stock Insider Monkey
10:17AM	Understanding LeMaitre Vascular's Ex-Dividend Date Benzinga
Nov-13-20 07:14AM	Should You Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming Dividend? Simply Wall St.
Nov-11-20 04:35PM	LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference GlobeNewswire
Nov-04-20 09:50AM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Nov-02-20 06:06AM	Earnings Beat: LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
Oct-29-20 07:15PM	LeMaitre Vascular (LMAT) Q3 Earnings and Revenues Top Estimates Zacks +7.53%
05:27PM	LeMaitre Vascular: Q3 Earnings Insights Benzinga
04:05PM	LeMaitre Vascular Announces Q3 2020 Financial Results GlobeNewswire
03:15PM	LeMaitre Vascular, Inc. to Host Earnings Call ACCESSWIRE
Oct-22-20 12:33PM	Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-09-20 06:18PM	LeMaitre Vascular Will Announce Third Quarter 2020 Earnings Results on October 29, 2020 GlobeNewswire
Sep-22-20 06:30PM	Sidoti Virtual Investor Conference ACCESSWIRE
05:46PM	Sidoti - Virtual Investor Conference ACCESSWIRE
Sep-17-20 03:15AM	Moving Average Crossover Alert: LeMaitre Vascular Zacks
Sep-16-20 09:47AM	How Much Does LeMaitre Vascular's (NASDAQ:LMAT) CEO Make? Simply Wall St.
Aug-31-20 03:33PM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Aug-21-20 06:49AM	Why You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming Dividend Simply Wall St.
Jul-31-20 12:09PM	Registration - Sidoti's 2020 Fall Virtual Investor Conference is Open Now ACCESSWIRE
Jul-30-20 04:28PM	Registration - Sidoti's 2020 Fall Virtual Investor Conference is Now Open. ACCESSWIRE
Jul-29-20 12:12PM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Jul-28-20 06:45AM	Party Time: Brokers Just Made Major Increases To Their LeMaitre Vascular, Inc. (NASDAQ:LMAT) Earnings Forecasts Simply Wall St.
Jul-27-20 06:44AM	Pinning Down LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) P/E Is Difficult Right Now Simply Wall St. -6.05%
Jul-26-20 10:58AM	LeMaitre Vascular, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next Simply Wall St.
Jul-24-20 12:07PM	LeMaitre Vascular (NASDAQ:LMAT) Shareholders Have Enjoyed An Impressive 103% Share Price Gain Simply Wall St. +10.30%
Jul-23-20 07:15PM	LeMaitre Vascular (LMAT) Tops Q2 Earnings and Revenue Estimates Zacks
05:14PM	Recap: LeMaitre Vascular Q2 Earnings Benzinga
04:25PM	LeMaitre Vascular Announces Q2 2020 Financial Results GlobeNewswire
Jul-16-20 12:31PM	Earnings Preview: LeMaitre Vascular (LMAT) Q2 Earnings Expected to Decline Zacks
Jul-10-20 03:11PM	LeMaitre Vascular Will Announce Second Quarter 2020 Earnings Results on July 23, 2020 GlobeNewswire
Jun-22-20 04:13PM	LeMaitre Vascular Acquires Artegraft GlobeNewswire
Jun-12-20 04:28PM	LeMaitre Vascular Inc (LMAT): Hedge Funds Are Turning Bearish Insider Monkey
Jun-09-20 02:44PM	A Look Into LeMaitre Vascular's Price Over Earnings Benzinga
Jun-01-20 05:30AM	Admedus Changes Name to Anteris Technologies Ltd GlobeNewswire
May-28-20 05:59PM	LeMaitre Vascular to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-20-20 03:56PM	Edited Transcript of LMAT earnings conference call or presentation 30-Apr-20 9:00pm GMT Thomson Reuters StreetEvents
May-12-20 10:35AM	LeMaitre Vascular to Present at the UBS Virtual Global Healthcare Conference GlobeNewswire
May-05-20 08:36AM	Trump Pushes for US-Made Medical Products: 4 Winners Zacks
May-01-20 10:01PM	LeMaitre Vascular (LMAT) Q1 2020 Earnings Call Transcript Motley Fool -7.44%
Apr-30-20 08:25PM	LeMaitre Vascular (LMAT) Meets Q1 Earnings Estimates Zacks -7.23%
04:05PM	LeMaitre Vascular Announces Q1 2020 Financial Results GlobeNewswire
Apr-23-20 12:32PM	Earnings Preview: LeMaitre Vascular (LMAT) Q1 Earnings Expected to Decline Zacks
Apr-13-20 04:50PM	LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results GlobeNewswire
Apr-09-20 09:22AM	Should You Worry About LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) CEO Salary Level? Simply Wall St. +6.43%
Mar-17-20 08:12AM	Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 37%? Simply Wall St. +14.90%
Mar-04-20 11:07AM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Feb-26-20 06:02AM	Is It Smart To Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend? Simply Wall St.
Feb-18-20 12:28PM	LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 GlobeNewswire
Feb-13-20 10:38AM	Walgreens U.S. Retail Pharmacy Rises Amid Reimbursement Woes Zacks
06:44AM	Edited Transcript of LMAT earnings conference call or presentation 6-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-11-20 10:41AM	LabCorp (LH) Rides on Solid Diagnostics Despite PAMA Issues Zacks
Feb-10-20 09:28AM	Here's Why You Should Add Zimmer (ZBH) to Your Portfolio Zacks
08:34AM	Hologic Expands Panther Portfolio With New Product Offerings Zacks
Feb-09-20 08:42AM	LeMaitre Vascular, Inc. Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Feb-07-20 07:32AM	The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga -19.51%
Feb-06-20 06:25PM	LeMaitre Vascular (LMAT) Q4 Earnings Match Estimates Zacks
04:05PM	LeMaitre Vascular Announces Q4 2019 Financial Results GlobeNewswire
Jan-30-20 12:31PM	Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-29-20 02:13PM	LeMaitre Vascular Will Announce Fourth Quarter 2019 Earnings Results on February 6, 2020 GlobeNewswire
Jan-26-20 05:36PM	3 Stocks With Fast-Growing Earnings GuruFocus.com
Jan-22-20 08:59AM	Shareholders Are Raving About How The LeMaitre Vascular (NASDAQ:LMAT) Share Price Increased 368% Simply Wall St.
Jan-10-20 05:00AM	Top Picks 2020- LeMaitre Vascular LMAT MoneyShow
Jan-03-20 11:45AM	LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020 GlobeNewswire
Jan-02-20 02:12PM	Does LeMaitre Vascular, Inc. (NASDAQ:LMAT) Have A Volatile Share Price? Simply Wall St.
Dec-14-19 07:18PM	Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy? Insider Monkey
Dec-09-19 12:46PM	Why LeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Quality Company Simply Wall St.
Nov-19-19 08:16AM	Shareholders Are Loving LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 1.0% Yield Simply Wall St.
Nov-15-19 06:35PM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Nov-14-19 09:30AM	EYE vs. LMAT: Which Stock Is the Better Value Option? Zacks
Oct-30-19 08:34PM	Did Hedge Funds Drop The Ball On LeMaitre Vascular Inc (LMAT) ? Insider Monkey
09:22AM	Don't Ignore The Fact That This Insider Just Sold Some Shares In LeMaitre Vascular, Inc. (NASDAQ:LMAT) Simply Wall St.
Oct-29-19 04:26PM	Here's Why You Should Add ResMed (RMD) to Your Portfolio Zacks
05:29AM	Edited Transcript of LMAT earnings conference call or presentation 23-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
Oct-23-19 05:25PM	LeMaitre Vascular (LMAT) Q3 Earnings and Revenues Beat Estimates Zacks
04:05PM	LeMaitre Vascular Announces Q3 2019 Financial Results GlobeNewswire
Oct-16-19 10:32AM	LeMaitre Vascular (LMAT) Reports Next Week: What to Know Ahead of the Release Zacks
Oct-14-19 10:45AM	Are Insiders Selling LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock? Simply Wall St.
Oct-13-19 07:00PM	LeMaitre Vascular Acquires Biologic Patch Business from Admedus GlobeNewswire
Oct-11-19 03:36PM	LeMaitre Vascular Will Announce Third Quarter 2019 Earnings Results on October 23, 2019 GlobeNewswire
Oct-02-19 09:30AM	EYE vs. LMAT: Which Stock Should Value Investors Buy Now? Zacks
Sep-24-19 08:20AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Earns Among The Best Returns In Its Industry Simply Wall St.
Sep-13-19 09:15PM	Lemaitre Vascular Inc (LMAT) Chairman and CEO George W Lemaitre Sold $1.3 million of Shares GuruFocus.com
Sep-06-19 08:35AM	Here's Why You Should Invest in Chemed (CHE) Stock Right Now Zacks
Sep-05-19 07:17AM	Here's Why You Should Invest in Edwards Lifesciences (EW) Now Zacks
Sep-04-19 06:45AM	Is LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) CEO Paid Enough Relative To Peers? Simply Wall St.
Aug-27-19 08:56AM	Here's Why You Should Add Abbott (ABT) to Your Portfolio Zacks
Aug-26-19 09:00AM	LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
Aug-23-19 08:37AM	Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety Zacks
Aug-22-19 07:31AM	NuVasive's New TLIF Implant Broadens Spine Surgery Option Zacks
Aug-20-19 09:03AM	Boston Scientific's (BSX) Vercise Gevia DBS Gets FDA Nod Zacks
Aug-17-19 08:18AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT)'s Could Be A Buy For Its Upcoming Dividend Simply Wall St.
Aug-14-19 09:33AM	Myriad Genetics (MYGN) Q4 Earnings Lag Estimates, Revenues Up Zacks
Aug-12-19 08:41AM	National Vision (EYE) Q2 Earnings Lag Estimates, Margins Down Zacks

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. The company markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LeMaitre George W	Chairman and CEO	Dec 23	Option Exercise	30.19	56,314	1,699,956	2,839,428	Dec 28 06:36 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 22	Option Exercise	0.00	6	0	7,102	Dec 23 09:35 PM
Roberts David B	President and Director	Dec 22	Option Exercise	0.00	6	0	53,734	Dec 23 09:26 PM
LeMaitre George W	Chairman and CEO	Dec 22	Option Exercise	0.00	18	0	2,783,629	Dec 23 09:49 PM
Kamke Trent G	Senior V. P., Operations	Dec 22	Option Exercise	0.00	3	0	3,498	Dec 23 09:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 19	Option Exercise	0.00	11	0	7,360	Dec 23 09:35 PM
Roberts David B	President and Director	Dec 19	Option Exercise	0.00	11	0	53,992	Dec 23 09:26 PM
LeMaitre George W	Chairman and CEO	Dec 19	Option Exercise	0.00	36	0	2,784,717	Dec 23 09:49 PM
Kamke Trent G	Senior V. P., Operations	Dec 19	Option Exercise	0.00	9	0	3,618	Dec 23 09:14 PM
Roush John A	Director	Dec 08	Sale	36.42	20,000	728,308	7,500	Dec 10 05:39 PM
Pellegrino Joseph P JR	Chief Financial Officer	Nov 25	Option Exercise	18.63	29,633	552,127	36,475	Nov 30 05:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Nov 25	Sale	41.35	30,802	1,273,567	5,673	Nov 30 05:14 PM
Jasinski Lawrence J	Director	Nov 24	Option Exercise	28.72	7,500	215,400	15,833	Nov 25 09:41 PM
Jasinski Lawrence J	Director	Nov 24	Sale	39.50	7,500	296,250	8,333	Nov 25 09:41 PM
Kamke Trent G	Senior V. P., Operations	Nov 24	Sale	39.99	18,609	744,157	2,838	Nov 25 09:09 PM
LeMaitre George W	Chairman and CEO	Nov 20	Sale	37.69	2,000	75,377	10,000	Nov 20 09:35 PM
LeMaitre George W	Chairman and CEO	Nov 19	Sale	37.53	2,000	75,056	12,000	Nov 20 09:35 PM
LeMaitre George W	Chairman and CEO	Nov 18	Sale	38.09	2,000	76,188	14,000	Nov 18 08:36 PM
LeMaitre George W	Chairman and CEO	Nov 17	Sale	38.25	2,000	76,508	16,000	Nov 18 08:36 PM
LeMaitre George W	Chairman and CEO	Nov 16	Sale	38.12	2,000	76,242	18,000	Nov 18 08:36 PM
LeMaitre George W	Chairman and CEO	Nov 09	Sale	36.60	134,312	4,916,142	2,779,820	Nov 12 04:58 PM
LeMaitre George W	Chairman and CEO	Oct 30	Sale	35.74	37,209	1,329,924	2,914,132	Nov 02 07:58 PM
LeMaitre George W	Chairman and CEO	Oct 29	Sale	35.27	55,792	1,968,007	2,951,341	Nov 02 07:58 PM
LeMaitre George W	Chairman and CEO	Oct 23	Option Exercise	16.83	44,479	748,692	3,007,133	Oct 27 08:51 PM
Roberts David B	President and Director	Oct 21	Option Exercise	11.43	8,748	99,990	52,305	Oct 23 05:19 PM
LeMaitre George W	Chairman and CEO	Sep 25	Sale	33.98	724	24,599	20,000	Sep 29 09:26 PM
LeMaitre George W	Chairman and CEO	Sep 24	Sale	33.88	3,216	108,953	20,724	Sep 25 09:58 PM
LeMaitre George W	Chairman and CEO	Sep 23	Sale	33.65	6,060	203,898	23,940	Sep 25 09:58 PM
Roberts David B	President and Director	Aug 14	Buy	28.35	7,074	200,513	43,557	Aug 17 08:56 AM
LeMaitre George W	Chairman and CEO	Jul 25	Option Exercise	0.00	86	0	2,963,433	Jul 28 09:37 PM
Pellegrino Joseph P JR	Chief Financial Officer	Jul 25	Option Exercise	0.00	31	0	7,111	Jul 28 09:25 PM
Roberts David B	President and Director	Jul 25	Option Exercise	0.00	31	0	36,752	Jul 28 09:20 PM
Kamke Trent G	Senior V. P., Operations	Jul 25	Option Exercise	0.00	12	0	21,570	Jul 28 09:12 PM
Kamke Trent G	Senior V. P., Operations	Jul 24	Sale	33.00	13,804	455,532	21,558	Jul 28 09:12 PM
O'Connor John James	Director	Jul 21	Option Exercise	11.43	7,500	85,725	69,210	Jul 23 06:15 PM
Roush John A	Director	Jul 15	Option Exercise	11.43	7,500	85,725	27,500	Jul 16 09:25 PM
LeMaitre George W	Chairman and CEO	Jul 08	Option Exercise	12.57	23,621	296,916	2,963,347	Jul 16 09:51 PM
Kamke Trent G	Senior V. P., Operations	Feb 20	Option Exercise	11.49	18,005	206,876	49,587	Feb 24 04:01 PM
Kamke Trent G	Senior V. P., Operations	Feb 20	Sale	31.00	14,225	440,975	35,362	Feb 24 04:01 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience